36 results on '"Sundberg J"'
Search Results
2. Drying of cable backfill by vapour diffusion balanced by capillary water suction: a laboratory experiment with altered groundwater levels
3. 55P Assessment of cardiovascular biomarkers for individualised treatment decision in small cell lung cancer (SCLC)
4. Upgrades of the GANDALPH photodetachment detector towards the determination of the electron affinity of astatine
5. PALAESTRA: A phase II trial with short-course radiotherapy followed by chemotherapy as palliative treatment in esophageal adenocarcinoma
6. P1.12-16 LMW Heparin Adherence and Effects on Survival Within a Randomized Phase III Lung Cancer Trial (RASTEN)
7. Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
8. Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial
9. P1.15-007 Randomized Phase III Trial of Enoxaparin in Addition to Standard Treatment in Small Cell Lung Cancer: The RASTEN Trial
10. 246 miR-486 plays a protective role in hair follicle immune privilege collapse in alopecia areata
11. 500 A novel Abcc6 knockout rat model of PXE: Perfusion studies revealed the critical role of liver in PXE
12. 409 Profiling of epidermal lipids to identify potential biomarkers of atopic dermatitis
13. 935 Early-stage induction of ERK1/2 and NFkB pathways is essential for more rapid cutaneous healing in mice
14. 875 Exploring the role of microRNAs in alopecia areata
15. Process optimization for large-scale hydrogen liquefaction
16. 160 Demonstration of the critical role of the liver in systemic PPi homeostasis using a novel Abcc6 knockout rat model of PXE
17. A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
18. A Randomized Study of Kras-Stratified Maintenance Therapy with Bevacizumab, Erlotinib or Metronomic Capecitabine After First Line Induction Treatment of Metastatic Colorectal Cancer: the Nordic Act2 Trial
19. Can fisheries management be quantified?
20. Mechanisms for compositional variations of coatings sputtered from a WS2 target
21. A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial
22. Extreme friction reductions during initial running-in of W–S–C–Ti low-friction coatings
23. Increasing risk for negative ozone impacts on vegetation in northern Sweden
24. An electrical approach to wave energy conversion
25. The Functional Relevance of the Type 1 Cytokines IFN-γ and IL-2 in Alopecia Areata of C3H/HeJ Mice
26. The Pathogenesis of Advanced Cervical Cancer Provides the Basis for an Empirical Therapeutic Vaccine
27. PCV5: COST OF TREATMENT AND PREVALENCE OF CARDIOVASCULAR DISEASE COMORBIDITIES AND RISK FACTORS IN THE SEVERE AND PERSISTENTLY MENTALLY ILL
28. Protein binding of mercury in milk and plasma from mice and man — a comparison between methylmercury and inorganic mercury
29. Immunomodulating effects after perinatal exposure to methylmercury in mice
30. Effects of infection with bovine virus diarrhoea virus on health and reproductive performance in 213 dairy herds in one county in Sweden
31. A systems approach to municipal solid waste management: A pilot study of G�teborg
32. Phonatory control in male singing: A study of the effects of subglottal pressure, fundamental frequency, and mode of phonation on the voice source
33. Methylmercury induced alterations in the nerve growth factor level in the developing brain
34. Influence of body posture and lung volume on subglottal pressure control during singing
35. Breathing muscle activity and subglottal pressure dynamics in singing and speech
36. Breathing for singing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.